Association of trabecular bone score corrected for tissue thickness with glucose metabolism in acromegaly
- PMID: 39726849
- PMCID: PMC11669998
- DOI: 10.3389/fendo.2024.1448566
Association of trabecular bone score corrected for tissue thickness with glucose metabolism in acromegaly
Abstract
Introduction: Acromegaly is associated with increased vertebral fracture (VF) risk regardless of bone mineral density (BMD). However, the vertebral trabecular compartment is still low; a possible contributor to this may be impaired glucose metabolism (GM) which frequently complicates acromegaly. Additionally, soft tissue thickness may confound bone imaging in acromegaly patients.
Objective: This study aims to assess the association of GM with BMD, trabecular bone score adjusted for BMI (TBSBMI), and trabecular bone score adjusted for tissue thickness (TBSTT) among acromegaly subjects.
Patients and methods: A cross-sectional study was performed among 70 consecutive acromegaly patients (24 male/46 female, aged 55.1 years) divided in two subgroups: abnormal GM (n = 35) and normal GM (n = 35). Using DXA, BMD, TBSBMI, TBSTT, and VF screening were performed.
Results: In all subjects, TBSTT was higher (mean 9.5%) than TBSBMI. Abnormal GM subjects had lower TBSBMI (1.166 ± 0.15) than normal GM subjects (1.232 ± 0.12; p < 0.05). No between-group difference in TBSTT or BMD was observed. In a multiple regression model, the best predictor of TBSTT was HbA1c (p = 0.002). None of the DXA measures or GM parameters was a significant predictor of VF (n = 7).
Conclusion: The abnormal GM acromegaly subjects had lower TBSBMI than those with normal GM. TBSTT was higher than TBSBMI, and no between-group difference based on GM status was observed. TBSTT was significantly associated with GM parameters, notably HbA1c. The relationship of TBSTT with GM parameters may imply an effect of GM on trabecular bone microstructure in patients with acromegaly; a further study is indicated.
Keywords: acromegaly; bone mineral density; glucose metabolism; tissue thickness; trabecular bone score.
Copyright © 2024 Kužma, Vaňuga, Pávai, Killinger, Hans, Binkley, Payer and Jackuliak.
Conflict of interest statement
DH is co-founder and CEO of Med-Imaps. The remaining authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.
Figures


Similar articles
-
Assessment of trabecular bone score using updated TBSTT in anorexia nervosa-The AN-BO study.PLoS One. 2024 Oct 18;19(10):e0311499. doi: 10.1371/journal.pone.0311499. eCollection 2024. PLoS One. 2024. PMID: 39423193 Free PMC article.
-
Updated trabecular bone score accounting for the soft tissue thickness (TBSTT) demonstrated significantly improved bone microstructure with denosumab in the FREEDOM TBS post hoc analysis.Osteoporos Int. 2022 Dec;33(12):2517-2525. doi: 10.1007/s00198-022-06549-x. Epub 2022 Sep 17. Osteoporos Int. 2022. PMID: 36115888 Free PMC article.
-
Romosozumab improves microarchitecture as assessed by tissue thickness-adjusted trabecular bone score in postmenopausal women with osteoporosis.J Bone Miner Res. 2025 Feb 2;40(2):193-200. doi: 10.1093/jbmr/zjae194. J Bone Miner Res. 2025. PMID: 39656908 Free PMC article. Clinical Trial.
-
Trabecular Bone Score as an Index of Bone Fragility in Patients with Acromegaly: A Systematic Review and Meta-Analysis.Neuroendocrinology. 2023;113(4):395-405. doi: 10.1159/000528199. Epub 2022 Nov 22. Neuroendocrinology. 2023. PMID: 36617407
-
Volumetric BMD by 3D-DXA and Trabecular Bone Score in Adults With Down Syndrome.J Clin Densitom. 2021 Oct-Dec;24(4):630-637. doi: 10.1016/j.jocd.2021.01.010. Epub 2021 Jan 30. J Clin Densitom. 2021. PMID: 33618949 Review.
References
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical